Stammdaten
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
Unternehmen & Branche
| Name | Better Therapeutics, Inc. |
|---|---|
| Ticker | BTTX |
| CIK | 0001832415 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 8000 · Services-Health Services |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 5.452 USD |
| Beta | 1,69 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2023-09-30 | 10-Q | -5,862,000 | -0.15 | 10,722,000 | -9,937,000 | |
| 2023-06-30 | 10-Q | -7,589,000 | -0.24 | 11,604,000 | -10,788,000 | |
| 2023-03-31 | 10-Q | -9,357,000 | -0.39 | 12,808,000 | -9,833,000 | |
| 2022-12-31 | 10-K | -39,760,000 | -1.69 | 22,943,000 | -899,000 | |
| 2022-09-30 | 10-Q | -11,405,000 | -0.48 | 28,221,000 | 7,252,000 | |
| 2022-06-30 | 10-Q | -9,928,000 | -0.42 | 37,103,000 | 18,054,000 | |
| 2022-03-31 | 10-Q | -9,662,000 | -0.41 | 40,291,000 | 27,425,000 | |
| 2021-12-31 | 10-K | -40,335,000 | -3.11 | 50,958,000 | 36,720,000 | |
| 2021-09-30 | 10-Q | -12,461,000 | -1.20 | 57,798,391 | -33,114,000 | |
| 2021-06-30 | 10-Q | -8,650,000 | -0.84 | 57,901,100 | -20,676,000 | |
| 2021-03-31 | 10-Q | -5,330,000 | 58,024,919 | -12,054,000 | ||
| 2020-12-31 | 10-K | 8,000 | -1,686 | 6,387,000 | -6,758,000 | |
| 2020-09-30 | 10-Q | -1,000 | -1,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.